Adcock Ingram to Delist Amidst Corporate Changes
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.
The NHI dream promises universal health coverage but faces staggering costs. Discover the financial hurdles ahead.
Analyze the claims made in the racial bias report and how they impact perceptions of fairness in medical scheme fraud.
There is an alarming connection between early smartphone use and mental health challenges in young adults. Find out more.
Robert F. Kennedy Jr. faces criticism following his HHS Secretary confirmation amid a significant measles outbreak.